Page 74 - Clinical Olfactory Working Group Consensus Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical olfactory working group consensus statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Olfactory Working Group Consensus Statement Today - Breaking & Trending Today

Welcome To IANS Live - SCIENCE - Covid jabs for kids: Pfizer to seek approval in Sep

Photo Credit: IANS
IANSLive
Washington, May 5 (IANS) Pharmaceutical major Pfizer will likely seek the US Food and Drug Administration s emergency authorisation to administer its coronavirus vaccine among children between the ages of 2 and 11 in September, the media reported.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 05-May-2021 ....

United States , Drug Administration , News Service , India Private , All Rights , ஒன்றுபட்டது மாநிலங்களில் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Welcome To IANS Live - NATION - US FDA to authorise Pfizer jabs for 12 to 15-year-old by next week

Photo Credit: IANS
IANSLive
Washington, May 4 (IANS) The US Food and Drug Administration (FDA) is planning to open Pfizer-BioNTech coronavirus vaccine for adolescents aged 12 to 15 years by early next week, according to federal officials, the media reported.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 04-May-2021 ....

United States , Drug Administration , News Service , India Private , All Rights , ஒன்றுபட்டது மாநிலங்களில் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Welcome To IANS Live - LatestNews - US FDA to authorise Pfizer jabs for 12 to 15-year-old by next week

Photo Credit: IANS
IANSLive
Washington, May 4 (IANS) The US Food and Drug Administration (FDA) is planning to open Pfizer-BioNTech coronavirus vaccine for adolescents aged 12 to 15 years by early next week, according to federal officials, the media reported.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 04-May-2021 ....

United States , Drug Administration , News Service , India Private , All Rights , ஒன்றுபட்டது மாநிலங்களில் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Welcome To IANS Live - SCIENCE AND TECHNOLOGY - US FDA to authorise Pfizer jabs for 12 to 15-year-old by next week

Photo Credit: IANS
IANSLive
Washington, May 4 (IANS) The US Food and Drug Administration (FDA) is planning to open Pfizer-BioNTech coronavirus vaccine for adolescents aged 12 to 15 years by early next week, according to federal officials, the media reported.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 04-May-2021 ....

United States , Drug Administration , News Service , India Private , All Rights , ஒன்றுபட்டது மாநிலங்களில் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Welcome To IANS Live - SCIENCE - Rs 15 cr still needed to take IISc's vax studies further

Photo Credit: IANS
IANSLive
Bengaluru, May 4 (IANS) The Covid-19 pandemic has not just battered the healthcare sector, but it has also resulted in financial crisis across sectors.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 04-May-2021 ....

India Private , News Service , All Rights , இந்தியா ப்ரைவேட் , செய்தி சேவை , அனைத்தும் உரிமைகள் ,